Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT02067650
Other study ID # MPSUS
Secondary ID
Status Completed
Phase N/A
First received August 13, 2013
Last updated January 23, 2018
Start date September 2013
Est. completion date December 2016

Study information

Verified date January 2018
Source Children's Hospital of Eastern Ontario
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Hardly any imaging studies specifically addressing the articular and periarticular structures in MPS patients are available at this point. The investigators propose to do for the first time a pilot study using musculoskeletal ultrasound in patients with various types of MPS.


Recruitment information / eligibility

Status Completed
Enrollment 18
Est. completion date December 2016
Est. primary completion date March 2016
Accepts healthy volunteers No
Gender All
Age group 2 Years to 99 Years
Eligibility Inclusion Criteria

- Diagnosis of Mucopolysaccharidosis

- Ability to collaborate with the ultrasound assessment

- Written informed consent from parents and patients over 14 years of age, assent from children 7 to 14 years

Exclusion Criteria

- Inability to collaborate with the ultrasound assessment

- Acute trauma to a joint that will be assessed in the 3 months preceding the study

- Coexistence of other pathology that is known to affect the respective joints

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Canada Children's Hospital of Eastern Ontario Ottawa Ontario

Sponsors (1)

Lead Sponsor Collaborator
Children's Hospital of Eastern Ontario

Country where clinical trial is conducted

Canada, 

Outcome

Type Measure Description Time frame Safety issue
Primary Power Doppler The primary objective is to determine whether patients with various types of MPS and at various stages of the disease exhibit abnormalities of the finger, wrist and knee joints as assessed by grey scale and Power Doppler ultrasonography. one time exam
Secondary Ultrasound scanning technique To determine the optimal ultrasound scanning technique for MPS patients given the potentially advanced joint contractures one time scan
Secondary Findings of synovitis or tenosynovitis To determine whether there are ultrasound findings indicative of synovitis or tenosynovitis one time scan
Secondary Differences between MPS I and IV To determine whether differences exist between MPS I and MPS IV one time scan
Secondary Differences between ERT and BMT To determine whether differences exist between patients with or without Enzyme Replacement Therapy (ERT) or Bone Marrow Transplants one time scan
Secondary Differences between severe and attenuated phenotypes To determine whether differences exist between severe and attenuated phenotypes one time scan
See also
  Status Clinical Trial Phase
Recruiting NCT04958070 - The Intensively Follow-up Examinations for Asymptomatic MPS I Infants in Taiwan
Withdrawn NCT05665036 - Safety and Efficacy of Encapsulated Allogeneic MPS-1 Therapy Phase 1/Phase 2
Terminated NCT02702115 - Ascending Dose Study of Genome Editing by the Zinc Finger Nuclease (ZFN) Therapeutic SB-318 in Subjects With MPS I Phase 1/Phase 2
Terminated NCT01572636 - Laronidase (Aldurazyme TM) Enzyme Replacement Therapy With Hematopoietic Stem Cell Transplant for Hurler Syndrome
Recruiting NCT04532047 - In Utero Enzyme Replacement Therapy for Lysosomal Storage Diseases Phase 1
Recruiting NCT03333200 - Longitudinal Study of Neurodegenerative Disorders